This grant, part of the Emergency Awards under the HEAL Initiative, is designed to combat the ongoing opioid public health crisis. It aims to support highly creative postdoctoral or newly independent Early Stage Investigators proposing novel, original, and insightful research. The primary purpose is to fund projects with the potential to significantly impact, test scientific paradigms, or advance key concepts related to pain, opioid use disorder (OUD), and overdose (OD). Applications are strongly encouraged to feature unexpected convergence of disciplines, explore new scientific directions, or employ innovative methodologies, ultimately contributing to a major breakthrough in biomedical research concerning these critical health issues. The award seeks to foster groundbreaking discoveries from promising early-career researchers.
Opportunity ID: 347631
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-TR-23-011 |
| Funding Opportunity Title: | Emergency Awards: HEAL Initiative- New Innovator Award (DP2 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Food and Nutrition Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.213 — Research and Training in Complementary and Integrative Health |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Apr 19, 2023 |
| Last Updated Date: | Apr 19, 2023 |
| Original Closing Date for Applications: | May 22, 2023 |
| Current Closing Date for Applications: | May 22, 2023 |
| Archive Date: | Jun 27, 2023 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $1,500,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | State governments County governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Small businesses For profit organizations other than small businesses City or township governments Independent school districts Native American tribal governments (Federally recognized) Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | NCATS is issuing this FOA in response to the declared public health emergency issued by the Secretary, HHS. Please see Determination that a Public Health Emergency Exists Nationwide as the Result of the Opioid Crisis as renewed in Renewal of the Determination that a Public Health Emergency Exists Nationwide as the Result of the Continued Consequences of the Opioid Crisis.The Helping End Addiction Long-Term (HEAL) New Innovator Award supports a postdoctoral or newly independent Early Stage Investigator of exceptional creativity who proposes novel, original and insightful research concepts with the potential to produce a major impact, test scientific paradigms, or advance key concepts on broad, important problems in biomedical research related to pain, opioid use disorder (OUD), and/or overdose (OD). Applications proposing unexpected convergence of disciplines, new scientific directions, or the use of novel methodologies are encouraged. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-TR-23-011.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 347631 Full Announcement-RFA-TR-23-011 -> RFA-TR-23-011-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00281260 | Apr 21, 2023 | May 22, 2023 | View |
Package 1
Mandatory forms
347631 RR_SF424_5_0-5.0.pdf
347631 PerformanceSite_4_0-4.0.pdf
347631 RR_OtherProjectInfo_1_4-1.4.pdf
347631 RR_KeyPersonExpanded_4_0-4.0.pdf
347631 PHS398_CoverPageSupplement_5_0-5.0.pdf
347631 PHS398_ResearchPlan_5_0-5.0.pdf
347631 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
347631 PHS_AssignmentRequestForm_3_0-3.0.pdf
347631 RR_Budget10_3_0-3.0.pdf
347631 RR_SubawardBudget10_30_3_0-3.0.pdf
347631 PHS398_ModularBudget_1_2-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
